imvaria

imvaria.com

imvaria was founded in 2019 by a team of physician-engineers from Stanford and Google, seeking to empower clinicians and improve patient outcomes through the development and application of modern computer science techniques to complex and serious diseases. The company's Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning. imvaria's lead software effort is assigned FDA's Breakthrough Device Designation.